India Immunoassay Market to Grow with a CAGR of 6.25% through 2030
Technological advancements in immunoassay instruments
and increasing prevalence of chronic diseases is expected to drive the India
Immunoassay Market growth in the forecast period, 2026-2030.
According to TechSci Research report, “India
Immunoassay Market - By Region, Competition, Forecast
& Opportunities, 2030F”, the India Immunoassay Market stood at USD 1.19
Billion in 2024 and is expected to reach USD 1.70 Billion by 2030 with a CAGR
of 6.25% during the forecast period. Point-of-care (POC) testing has emerged as
a rapidly growing trend in the India Immunoassay Market, driven by the
increasing need for fast, accurate, and on-site diagnostic solutions. POC
immunoassays enable healthcare providers to obtain results within minutes,
without the need for specialized laboratory equipment. This is particularly
beneficial in rural and underserved regions, where access to advanced medical
facilities and trained personnel may be limited. The ability to conduct tests
in local clinics, pharmacies, or even at home is transforming how healthcare is
delivered across the country, making diagnostics more accessible and
convenient. One of the key drivers of this trend is the demand for quick
diagnostic results. In emergency situations or for routine monitoring of
chronic conditions, the ability to obtain immediate test results is crucial for
timely interventions. POC tests allow for faster decision-making, enabling
healthcare providers to administer treatments without delay, which is
especially critical in conditions like infectious diseases, diabetes, and
cardiovascular diseases. This capability is particularly important in a country
like India, where timely interventions can significantly impact patient
outcomes, particularly in rural areas where medical facilities may be scarce.
The rise of home diagnostics further complements the
POC testing trend. Increasingly, individuals are opting to manage their health
conditions at home, particularly chronic conditions like diabetes, thyroid
disorders, and hypertension. Immunoassay kits for self-testing are now more
widely available, allowing patients to monitor their health without needing to
visit a clinic or hospital. This convenience is changing the traditional
healthcare model, empowering individuals to take charge of their own health and
reducing the burden on overcrowded healthcare facilities. Furthermore, the
affordability and ease of use of these kits are driving their adoption among
consumers. The expanding availability of over-the-counter immunoassay testing
kits and the growing acceptance of home-based healthcare are contributing to
the widespread adoption of POC testing. This trend is expected to continue,
with innovations in user-friendly, cost-effective diagnostic solutions playing
a key role in meeting the healthcare demands of India's diverse population.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "India Immunoassay Market”
The India Immunoassay Market is segmented into
product, technology, indication, end user, regional distribution, and company
Based on end user, Hospitals & Clinics segments
currently dominated in the Indian immunoassay market due to several key
factors. These establishments not only manage a large inflow of patients
on a regular basis but also possess the necessary infrastructure and expertise
to conduct immunoassays efficiently. This makes them the ideal setting for
carrying out diagnostic tests that require precision and accuracy. The accessibility of hospitals and clinics to a broad
population ensures that diagnostic services reach a wide range of individuals
across India. This is especially crucial in a country with a diverse and
geographically dispersed population, where ensuring access to reliable
diagnostic methods is of utmost importance. The urgent need for quick and
accurate diagnostic methods within healthcare settings, such as hospitals and
clinics, further drives the demand for immunoassays. With the rising burden of
diseases and the need for prompt diagnosis, immunoassays play a vital role in
enabling healthcare professionals to make timely and informed decisions for
their patients. The dominant presence of immunoassays in hospitals and clinics
across India can be attributed to the unique combination of managing a large
patient volume, accessibility to a diverse population, and the urgent
requirement for reliable diagnostic methods.
Based on region, Southern India shows the
fastest growth rate in the Indian immunoassay market. This can be attributed to
several key factors. The region houses a large proportion of India's
biotechnology and pharmaceutical companies, making it a strategic hub for the
development and application of immunoassays. The concentration of industry
expertise and resources in this area fuels innovation and drives advancements
in immunoassay technology.
Major companies operating in India Immunoassay Market
are:
- F.
Hoffmann-La Roche Ltd.
- Abbott
India Ltd.
- BioMérieux
India Pvt. Ltd.
- Bio-Rad
laboratories India Pvt.Ltd
- Becton
Dickinson Pvt.Ltd
- Thermo
Fisher Scientific India Pvt. Ltd.
- Danaher
India (DHR Holding India Pvt. Ltd.)
- Siemens
Healthcare Private Limited
- Randox
Laboratories (India) Pvt. Ltd.
- Sysmex
India Pvt. Ltd.
Download Free Sample Report
Customers can also request for 10% free customization
on this report
“The future of India's immunoassay market appears
robust and promising, primarily driven by increasing healthcare awareness, the
prevalence of chronic and infectious diseases, and advancements in
biotechnological research. As the Indian population continues to grow,
the need for effective and efficient diagnostic tools becomes increasingly
crucial. The immunoassay market plays a vital role in providing accurate and
timely detection of diseases, helping healthcare professionals make informed
decisions for patient care. The rising healthcare awareness among the
population, coupled with the increasing prevalence of chronic and infectious
diseases, creates a favorable environment for the immunoassay market to thrive.
The future of India's immunoassay market is bright, driven by various factors
such as increasing healthcare awareness, the prevalence of diseases,
advancements in biotechnology, and government support. With ongoing research
and development, the immunoassay market is expected to witness continuous growth,
playing a pivotal role in improving healthcare outcomes for the Indian
population”, said Mr. Karan Chechi, Research Director of TechSci Research, a
research-based management consulting firm.
“India Immunoassay Market By Product
(Reagents and Kits, Analyzers/Instruments, Software and Services), By
Technology (Radioimmunoassay (RIA), Enzyme Immunoassays (EIA), Fluoro
Immnoassay (FIA), Chemiluminescence Immunoassay (CLIA), Rapid Test, Others), By
Indication (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology,
Infectious Diseases, Autoimmune Diseases, Others), By End User (Hospitals &
Clinics, Pharmaceutical & Biotechnology Companies, Academic & Research
Institutions, Others), By Region, Competition, Forecast & Opportunities,
2020-2030F”, has evaluated the
future growth potential of India Immunoassay Market and provides statistics
& information on market size, structure and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in India Immunoassay Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com